What is Speech Pathology Group?
Speech Pathology Group (SPGCT) is a woman-owned, multidisciplinary practice headquartered in Connecticut, specializing in evidence-based therapy services for children and adults. Their offerings encompass a comprehensive suite of therapies, including speech, occupational, physical, and applied behavior analysis (ABA). SPGCT is committed to delivering high-quality care, fostering collaboration among its professionals, and providing robust support to families. The organization serves clients and school districts throughout Connecticut, with a focus on enhancing accessibility through flexible financing options.
How much funding has Speech Pathology Group raised?
Speech Pathology Group has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Speech Pathology Group
PPP
Public-Private Partnership
What's next for Speech Pathology Group?
The substantial capital infusion, characterized as a large-scale late-stage funding event, positions Speech Pathology Group for significant expansion and operational enhancement. This strategic backing is likely to fuel further development of their service offerings, potentially including geographic expansion beyond Connecticut or the integration of new therapeutic modalities. The company's focus on evidence-based practices and family support, combined with this recent investment, suggests a strategic push to solidify its market leadership and address growing demand for specialized therapy services.
See full Speech Pathology Group company page
